Smith & Nephew (SNN) Total Debt Growth (3y) (2012 - 2023)
Smith & Nephew (SNN) Total Debt Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -14.39% |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 31.21% |
| Dec 31, 2021 | -37.27% |
| Dec 31, 2020 | -38.24% |
| Dec 31, 2018 | -0.34% |
| Jun 30, 2018 | 44.66% |
| Dec 31, 2017 | -5.26% |
| Dec 31, 2016 | 61.60% |
| Dec 31, 2015 | 46.78% |
| Jun 30, 2015 | -182.93% |
| Dec 31, 2014 | 374.10% |
| Dec 31, 2013 | -15.24% |
| Dec 31, 2012 | -24.56% |
| Sep 29, 2012 | 3,729.12% |
| Jun 30, 2012 | 27.16% |
| Mar 31, 2012 | 6,143.13% |